rs1561876
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001382567.1(STIM1):c.*367G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.796 in 334,640 control chromosomes in the GnomAD database, including 111,378 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.73 ( 43553 hom., cov: 31)
Exomes 𝑓: 0.86 ( 67825 hom. )
Consequence
STIM1
NM_001382567.1 3_prime_UTR
NM_001382567.1 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.144
Publications
23 publications found
Genes affected
STIM1 (HGNC:11386): (stromal interaction molecule 1) This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
STIM1 Gene-Disease associations (from GenCC):
- myopathy, tubular aggregate, 1Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- Stormorken syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- tubular aggregate myopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- combined immunodeficiency due to STIM1 deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.888 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STIM1 | NM_001382567.1 | c.*367G>A | 3_prime_UTR_variant | Exon 13 of 13 | ENST00000526596.2 | NP_001369496.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.726 AC: 110271AN: 151882Hom.: 43557 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
110271
AN:
151882
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.855 AC: 156188AN: 182640Hom.: 67825 Cov.: 0 AF XY: 0.862 AC XY: 84163AN XY: 97614 show subpopulations
GnomAD4 exome
AF:
AC:
156188
AN:
182640
Hom.:
Cov.:
0
AF XY:
AC XY:
84163
AN XY:
97614
show subpopulations
African (AFR)
AF:
AC:
2155
AN:
5932
American (AMR)
AF:
AC:
7304
AN:
9442
Ashkenazi Jewish (ASJ)
AF:
AC:
4008
AN:
4816
East Asian (EAS)
AF:
AC:
6751
AN:
8894
South Asian (SAS)
AF:
AC:
27588
AN:
30320
European-Finnish (FIN)
AF:
AC:
6226
AN:
7150
Middle Eastern (MID)
AF:
AC:
575
AN:
678
European-Non Finnish (NFE)
AF:
AC:
93519
AN:
105800
Other (OTH)
AF:
AC:
8062
AN:
9608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
992
1984
2976
3968
4960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.726 AC: 110289AN: 152000Hom.: 43553 Cov.: 31 AF XY: 0.728 AC XY: 54072AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
110289
AN:
152000
Hom.:
Cov.:
31
AF XY:
AC XY:
54072
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
15866
AN:
41418
American (AMR)
AF:
AC:
11783
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
2849
AN:
3472
East Asian (EAS)
AF:
AC:
3898
AN:
5154
South Asian (SAS)
AF:
AC:
4381
AN:
4814
European-Finnish (FIN)
AF:
AC:
8983
AN:
10570
Middle Eastern (MID)
AF:
AC:
229
AN:
294
European-Non Finnish (NFE)
AF:
AC:
59998
AN:
67984
Other (OTH)
AF:
AC:
1589
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1168
2336
3503
4671
5839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2623
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.